Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
8.83
+0.12 (1.38%)
At close: Aug 14, 2026, 4:00 PM EDT
8.90
+0.07 (0.79%)
After-hours: Aug 14, 2026, 7:36 PM EDT
Puma Biotechnology Employees
Puma Biotechnology had 179 employees as of December 31, 2025. The number of employees increased by 7 or 4.07% compared to the previous year.
Employees
179
Change (1Y)
7
Growth (1Y)
4.07%
Revenue / Employee
$1,291,866
Profits / Employee
$149,263
Market Cap
455.81M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 179 | 7 | 4.07% |
| Dec 31, 2024 | 172 | -13 | -7.03% |
| Dec 31, 2023 | 185 | -7 | -3.65% |
| Dec 31, 2022 | 192 | -4 | -2.04% |
| Dec 31, 2021 | 196 | -71 | -26.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cabaletta Bio | 158 |
| Ocugen | 116 |
| Editas Medicine | 87 |
| Larimar Therapeutics | 71 |
| Prothena Corporation | 67 |
| Eupraxia Pharmaceuticals | 49 |
| X4 Pharmaceuticals | 45 |
| Inhibikase Therapeutics | 35 |
PBYI News
- 8 days ago - Puma Biotechnology price target raised to $6 from $5 at TD Cowen - TheFly
- 9 days ago - Puma Biotechnology reports Q2 EPS 19c vs 15c last year - TheFly
- 9 days ago - Puma Biotechnology sees Q3 revenue $56M-$59M - TheFly
- 9 days ago - Puma Biotechnology raises FY26 revenue to $224M-$231M from $222M-$229M - TheFly
- 9 days ago - Puma Biotechnology Earnings Call Transcript: Q2 2026 - Transcripts
- 9 days ago - Puma Biotechnology Earnings release: Q2 2026 - Filings
- 9 days ago - Puma Biotechnology Quarterly report: Q2 2026 - Filings
- 9 days ago - Puma Biotechnology Slides: Q2 2026 - Filings